drugset / Trial / NCT05362188
Topical Nicotinamide in Treatment of DLE
RandomizedParallel-groupTriple-blindTreatment
Summary
Cutaneous lupus erythematosus (CLE) is lupus affecting the skin. In this autoimmune disease, the body's immune system attacks healthy skin. There are 3 main types: Acute cutaneous lupus, Subacute cutaneous lupus, and Chronic cutaneous lupus ("discoid lupus"). Lupus most often appears between the ages of 20 and 50 years; it affects women more than men, and it may happen more in patients with a family history of lupus or other autoimmune diseases.
Timeline
- Start
- 2022-03-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotinamide | Other / unclassified | 2 % | Topical |
| Subject | Nicotinamide | Other / unclassified | 4 % | Topical |